Discovering Genetic Signatures Associated with Alzheimer's Disease in Tiled Whole Genome Sequence Data: Results from the Artificial Intelligence for Alzheimer's Disease (AI4AD) Consortium
Sarah Wait Zaranek, Alexander Wait ZaranekiD, Peter AmstutziD, Jingxuan BaoiD, Jiong CheniD, Tom CleggiD, Hannah Craft, Taeho JoiD, Brian Lee, Kwangsik T. NhoiD, Sophia I. ThomopoulosiD, Christos A. DavatzikosiD, Li SheniD, Heng HuangiD, Paul M. ThompsoniD, Andrew J. SaykiniD
Abstract
Currently, the ability to analyze large-scale whole genome sequence (WGS) data is limited due to both the size of the data and the inability of many existing tools to scale. To address this challenge, we use data "tiling" to efficiently partition whole genome sequences into smaller segments resulting in a simple numeric matrix of small integers. This lossless representation is particularly suitable for machine learning (ML) models. As an example of the benefits of tiling, we showcase results from tiled data as part of the Artificial Intelligence for Alzheimers Disease (AI4AD) consortium. AI4AD is a coordinated initiative to develop transformative AI approaches for high throughput analysis of next generation sequencing and related imaging, AD biomarker, and cognitive data. The collective effort integrates imaging, genomic, biomarker, and cognitive data to address fundamental barriers in AD prevention and drug discovery. One of the projects initial aims is to discover new genetic signatures in WGS data that can be used to understand AD risk and progression in conjunction with imaging, biomarker and cognitive data. We tiled and analyzed 15,000+ genomes from the Alzheimers Disease Sequencing Project (ADSP) and the Alzheimers Disease Neuroimaging Initiative (ADNI). We tile 11,762 genomes, a subset of the release which does not include family-based datasets (AD Cases: 4,983, age range: 50-90 years, mean age: 73.8 years). We illustrate the use of tiled data in ML classification methods to predict phenotypes. Specifically, we identify and prioritize tile variants/genetic variants that are possible genetic signatures for AD. The model shows added predictive value from variants of genes previously found to be associated with AD risk, age of onset, neurofibrillary tangle measurements, and other AD-related traits-including the APOE variant (rs429358).
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Alzheimer's Disease Sequencing Project Release 4 Whole Genome Sequencing Dataset
Yuk Yee Leung, Wan‐Ping Lee, … Li‐San Wang·Alzheimer s & DementiaPeer-reviewed·May 1, 2025
- Key variants via Alzheimer's Disease Sequencing Project whole genome sequence data
Yanbing Wang, Chloé Sarnowski, … for the Alzheimer's Disease Sequencing Project (ADSP)·Alzheimer s & DementiaPeer-reviewed·Mar 21, 2024
- LD-informed deep learning for Alzheimer's gene loci detection using WGS data
Taeho Jo, Paula J. Bice, … Alzheimer's Disease Sequencing Project·Alzheimer s & Dementia Translational Research & Clinical InterventionsPeer-reviewed·Jan 1, 2025
- Association of Common and Rare Variants with Alzheimer's Disease in over 13,000 Diverse Individuals with Whole-Genome Sequencing from the Alzheimer's Disease Sequencing Project
Wan‐Ping Lee, Seung Hoan Choi, … Gina Marie Peloso·Alzheimer s & DementiaPeer-reviewed·Oct 20, 2024
- Identifying Alzheimer's disease-related pathways based on whole-genome sequencing data
Yongheng Wang, Liu Taihang, … Zhijie Han·Computational and Structural Biotechnology JournalPeer-reviewed·Jan 1, 2025
- Region-based analysis of rare genomic variants in whole-genome sequencing datasets reveal two novel Alzheimer's disease-associated genes: DTNB and DLG2
Dmitry Prokopenko, Sanghun Lee, … Rudolph E. Tanzi·Molecular PsychiatryPeer-reviewed·Mar 4, 2022